PCN20 THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS...

Value in Health 2009 Vol. 12; Iss. 3

PCN20 THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)

RC Wielage, CE Muehlenbein, AM Liepa, SM Babineaux, RW Klein, LS Schwartzberg
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)73257-5
File:
PDF, 92 KB
english, 2009
Conversion to is in progress
Conversion to is failed